Kawin Technology Share-holding Co., Ltd.

Quick facts

Phase 3 pipeline

• KW-136
  KW-136 is an investigational therapeutic agent in phase 3 development by Kawin Technology.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Kawin Technology Share-holding Co., Ltd. portfolio CI brief
• Kawin Technology Share-holding Co., Ltd. pipeline updates RSS